479 filings
Page 4 of 24
4
PCSA
Processa Pharmaceuticals Inc
24 Jul 23
Processa Pharmaceuticals / Khoso Baluch ownership change
6:29pm
4
PCSA
Processa Pharmaceuticals Inc
24 Jul 23
Processa Pharmaceuticals / Geraldine Pannu ownership change
6:26pm
8-K
PCSA
Processa Pharmaceuticals Inc
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:18pm
8-K
PCSA
Processa Pharmaceuticals Inc
21 Jun 23
Regulation FD Disclosure
12:30pm
4
PCSA
Processa Pharmaceuticals Inc
12 Jun 23
Processa Pharmaceuticals / David Young ownership change
4:31pm
8-K
PCSA
Processa Pharmaceuticals Inc
24 May 23
Regulation FD Disclosure
2:05pm
8-K
PCSA
Processa Pharmaceuticals Inc
18 May 23
Regulation FD Disclosure
3:24pm
10-Q
2023 Q1
PCSA
Processa Pharmaceuticals Inc
Quarterly report
15 May 23
10:00am
8-K
PCSA
Processa Pharmaceuticals Inc
5 May 23
Regulation FD Disclosure
9:50pm
ARS
2022 FY
PCSA
Processa Pharmaceuticals Inc
1 May 23
Annual report to shareholders
10:02am
DEFA14A
PCSA
Processa Pharmaceuticals Inc
1 May 23
Additional proxy soliciting materials
10:01am
DEF 14A
PCSA
Processa Pharmaceuticals Inc
Definitive proxy
1 May 23
10:00am
4
David Young
14 Apr 23
Processa Pharmaceuticals / David Young ownership change
6:16pm
PRE 14A
PCSA
Processa Pharmaceuticals Inc
Preliminary proxy
14 Apr 23
4:30pm
4
David Young
13 Apr 23
Processa Pharmaceuticals / David Young ownership change
4:51pm
8-K
PCSA
Processa Pharmaceuticals Inc
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
10-K
2022 FY
PCSA
Processa Pharmaceuticals Inc
Annual report
30 Mar 23
12:00am
8-K
PCSA
Processa Pharmaceuticals Inc
22 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
PCSA
Processa Pharmaceuticals Inc
14 Mar 23
Regulation FD Disclosure
12:00pm
8-K
PCSA
Processa Pharmaceuticals Inc
13 Feb 23
Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
4:05pm